Soares, M.A.; Teixeira, D.M.T.; Gontijo, B.R.; Silva, C.M.S.; Morais, R.M.; Cardoso-Duarte, L.C.A.; Oliveira, J.R.; Furia, C.L.B.; Silva, I.C.R.d.
PCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients. Proceedings 2026, 137, 64.
https://doi.org/10.3390/proceedings2026137064
AMA Style
Soares MA, Teixeira DMT, Gontijo BR, Silva CMS, Morais RM, Cardoso-Duarte LCA, Oliveira JR, Furia CLB, Silva ICRd.
PCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients. Proceedings. 2026; 137(1):64.
https://doi.org/10.3390/proceedings2026137064
Chicago/Turabian Style
Soares, Micaela A., Dante M. T. Teixeira, Bruna R. Gontijo, Calliandra M. S. Silva, Rafael M. Morais, Ligia C. A. Cardoso-Duarte, Jamila R. Oliveira, Cristina L. B. Furia, and Izabel C. R. da Silva.
2026. "PCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients" Proceedings 137, no. 1: 64.
https://doi.org/10.3390/proceedings2026137064
APA Style
Soares, M. A., Teixeira, D. M. T., Gontijo, B. R., Silva, C. M. S., Morais, R. M., Cardoso-Duarte, L. C. A., Oliveira, J. R., Furia, C. L. B., & Silva, I. C. R. d.
(2026). PCSK9 and Thyroid Tumor Dynamics: Exploring the Metabolic–Oncogenic Interface in PTC Patients. Proceedings, 137(1), 64.
https://doi.org/10.3390/proceedings2026137064